CFLAR and breast carcinoma: Thus, we presume that CDDO-Me–induced downregulation of c-FLIPL, a caspase-8 inhibitor [20], may help tip the balance towards caspase-mediated apoptotic cell death in breast cancer cells undergoing progressive ER dilation.